Calamos Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,392
| Closed | -$243K | – | 316 |
|
|
2022
Q3 | $243K | Sell |
7,392
-1,218
| -14% | -$40K | 0.02% | 269 |
|
|
2022
Q2 | $271K | Buy |
8,610
+490
| +6% | +$15.4K | 0.02% | 273 |
|
|
2022
Q1 | $373K | Sell |
8,120
-2,203
| -21% | -$101K | 0.03% | 259 |
|
|
2021
Q4 | $632K | Sell |
10,323
-2,553
| -20% | -$156K | 0.05% | 206 |
|
|
2021
Q3 | $962K | Sell |
12,876
-1,350
| -9% | -$101K | 0.08% | 165 |
|
|
2021
Q2 | $1.32M | Buy |
14,226
+2,487
| +21% | +$230K | 0.1% | 139 |
|
|
2021
Q1 | $1.04M | Buy |
11,739
+2,421
| +26% | +$215K | 0.09% | 156 |
|
|
2020
Q4 | $869K | Buy |
9,318
+5,324
| +133% | +$497K | 0.08% | 155 |
|
|
2020
Q3 | $254K | Buy |
+3,994
| New | +$254K | 0.03% | 237 |
|